Form 4: Ovid Therapeutics COO Margaret Alexander Sells Shares to Cover Tax Obligations

Margaret A. Alexander, COO of Ovid Therapeutics Inc., sold 5,279 shares of common stock on February 26, 2025, at a price of $0.56 per share to cover statutory tax withholding obligations related to the vesting of restricted stock units.

Summary

• On February 26, 2025, Margaret A. Alexander, the President and COO of Ovid Therapeutics Inc., sold 5,279 shares of the company's common stock.
• The shares were sold at a price of $0.56 per share.
• This transaction was executed to cover statutory tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Alexander directly owns 73,406 shares of Ovid Therapeutics Inc.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transaction is a routine sale to cover tax obligations and doesn't reflect a change in the executive's overall confidence in the company.

Industry Context

Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among corporate executives and do not necessarily indicate a negative outlook on the company's future.

Stakeholder Impact

• The sale of shares by a company executive could have a minor impact on shareholder sentiment, but is unlikely to have a significant long-term effect.

Key Dates